These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7906950)

  • 1. Intermittent subcutaneous infusion of opioids in hospice home care: an effective, economical, manageable option.
    Crane RA
    Am J Hosp Palliat Care; 1994; 11(1):8-12. PubMed ID: 7906950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent subcutaneous injections for symptom control in hospice care: a retrospective investigation.
    Letizia M; Shenk J; Jones TD
    Hosp J; 2000; 15(2):1-11. PubMed ID: 11271156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent subcutaneous injections of pain medication: effectiveness, manageability, and satisfaction.
    Letizia M; Shenk J; Jones TD
    Am J Hosp Palliat Care; 1999; 16(4):585-92. PubMed ID: 10661066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors that enable the patients to live their life till death at home by controlling cancer-pains with continuous subcutaneous injection of opioids-case reports of 3 patients with a terminal cancer].
    Yoshimura M; Takeu R
    Gan To Kagaku Ryoho; 2001 Dec; 28 Suppl 1():110-3. PubMed ID: 11787275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of cancer pain control in home hospice care--assessment by family members].
    Okuyama H; Terashima H; Matsumoto S; Takahashi Y; Ando R; Oku U; Tan K; Hirayama K
    Gan To Kagaku Ryoho; 1998 Dec; 25 Suppl 4():605-9. PubMed ID: 9884650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
    Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
    J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of sublingual opioids in palliative medicine.
    Reisfield GM; Wilson GR
    J Palliat Med; 2007 Apr; 10(2):465-75. PubMed ID: 17472518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project.
    Radbruch L; Trottenberg P; Elsner F; Kaasa S; Caraceni A
    Palliat Med; 2011 Jul; 25(5):578-96. PubMed ID: 21708861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outpatient opiate therapy in cancer patients during their last days of life].
    Maier R; Maier A; Müller-Busch C
    Schmerz; 2008 Apr; 22(2):148, 150-5. PubMed ID: 18210161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.
    Weschules DJ; Bain KT; Reifsnyder J; McMath JA; Kupperman DE; Gallagher RM; Hauck WW; Knowlton CH
    Pain Med; 2006; 7(4):320-9. PubMed ID: 16898943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
    Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of pain in terminally ill cancer patients with difficulty swallowing.
    Coluzzi PH; Fairbairn BS
    Am J Hosp Palliat Care; 1999; 16(6):731-7. PubMed ID: 11094910
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternatives to oral opioids for cancer pain.
    Mercadante S; Fulfaro F
    Oncology (Williston Park); 1999 Feb; 13(2):215-20, 225; discussion 226-9. PubMed ID: 10079471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous infusion of opiates at end-of-life.
    Anderson SL; Shreve ST
    Ann Pharmacother; 2004 Jun; 38(6):1015-23. PubMed ID: 15122000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of human recombinant hyaluronidase-enhanced subcutaneous hydration and opioid administration for sickle cell disease acute pain episodes.
    Sandoval M; Coleman P; Govani R; Siddiqui S; Todd KH
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):10-8. PubMed ID: 23527666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use.
    Walsh D; Perin ML; McIver B
    Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to use rescue-dose in home hospice care].
    Yoshizawa A; Gyouda Y; Ishiguro T; Yoshida S; Yoshizawa T
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():194-5. PubMed ID: 15645769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of fentanyl in childbirth: an observational study on the clinical effectiveness of fentanyl for mother and neonate.
    Fleet J; Jones M; Belan I
    Midwifery; 2014 Jan; 30(1):36-42. PubMed ID: 23523191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration.
    Koshy RC; Kuriakose R; Sebastian P; Koshy C
    J Pain Palliat Care Pharmacother; 2005; 19(1):27-33. PubMed ID: 15814512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.